Korro Bio, Inc.
KRRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $0 | $0 | $14 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $4 |
| Gross Profit | $2 | $0 | $0 | $10 |
| % Margin | 100% | – | – | 72.7% |
| R&D Expenses | $64 | $57 | $42 | $59 |
| G&A Expenses | $31 | $24 | $17 | $0 |
| SG&A Expenses | $31 | $37 | $17 | $35 |
| Sales & Mktg Exp. | $0 | $13 | $0 | $0 |
| Other Operating Expenses | $0 | -$9 | $0 | $0 |
| Operating Expenses | $94 | $85 | $59 | $94 |
| Operating Income | -$92 | -$85 | -$59 | -$84 |
| % Margin | -4,047.1% | – | – | -597.3% |
| Other Income/Exp. Net | $8 | $3 | $1 | -$1 |
| Pre-Tax Income | -$83 | -$81 | -$58 | -$85 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$84 | -$81 | -$58 | -$85 |
| % Margin | -3,680.4% | – | – | -602% |
| EPS | -9.37 | -53.09 | -227.58 | -4.94 |
| % Growth | 82.4% | 76.7% | -4,506.9% | – |
| EPS Diluted | -9.37 | -53.08 | -227.42 | -4.94 |
| Weighted Avg Shares Out | 9 | 2 | 0 | 4 |
| Weighted Avg Shares Out Dil | 9 | 2 | 0 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $4 | $4 | $3 | $4 |
| EBITDA | -$88 | -$81 | -$56 | -$80 |
| % Margin | -3,890.1% | – | – | -569.1% |